Parameter
| Biomarker | IL-6 | Full name | Interleukin-6 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | 21 kDa | Core Functional Dimensions | Susceptibility, prognosis, surveillance |
| Disease | hypertension | Disease Subtypes | / | ||
| Organ | Immune cells , hepatocytes | Test Sample / Technology Platform | Serum/plasma (ELISA, flow cytometry) | ||
| Pathobiological Mechanisms | It mediates inflammatory cascades, induces vascular smooth muscle cell proliferation, endothelial dysfunction, and promotes vascular remodeling | ||||
| Clinical Availability Status | Research validation/clinical application: It is widely used in the study of inflammatory mechanisms of hypertension, and partly used in the stratification of high-risk patients | ||||
| Notes and Dynamics | It is a key inflammatory mediator in hypertension complicated with metabolic syndrome. Anti-il-6 therapy may provide a new direction for refractory hypertension | ||||